Better Buy for Your TFSA: Bank of Nova Scotia (TSX:BNS) or Toronto-Dominion Bank (TSX:TD)?

Bank of Nova Scotia (TSX:BNS) (NYSE:BNS) and Toronto-Dominion Bank (TSX:TD) (NYSE:TD) are both interesting options for dividend investors, but which is the better buy?

| More on:

The financial services industry isn’t necessarily the best to turn to when looking for dividend stocks, but many companies within the industry are worth a mention. Two of the largest Canadian banks, Bank of Nova Scotia (TSX:BNS)(NYSE:BNS) and Toronto-Dominion Bank (TSX:TD) (NYSE:TD) are excellent options to consider when looking for stocks to fill your TFSA with constant dividends. But which of them is the better option? Let’s dig in and find out which bank is the better dividend stud.

Core operations

The two banking giants have different strategies. TD derives most of its earnings —a little less than two-thirds — from its domestic operations. Further, TD is arguably the Canadian bank with the strongest U.S. operations. The company derives approximately 30% of its earnings from the U.S. and owns more branches south of the border than any of its peers.

Scotiabank’s earnings are much more dispersed than that of TD. About half of BNS’ revenues are generated locally, with most of the remaining coming from Latin American, The Caribbeans, Asia, and the U.S. BNS’ exposure to secondary markets is a double-edged sword, presenting both great risks and opportunities.

Recent financial results

TD recently benefited from favourable tax laws due to its greater exposure to the U.S. market, but the bank was hit by various macro-economic factors. Most notably, the company’s Wholesale banking reported a net loss of $17 million during the first quarter of 2019, down from net earnings of $278 million compared to the same period of the previous fiscal year.

This loss was mainly due to lower trading revenue (reflecting the adverse conditions that hit global equity markets) and higher expenses. However, these headwinds are expected to subside. With equity markets coming back with a vengeance since the beginning of the year, TD is poised to benefit.

Scotiabank is currently undergoing a series of acquisitions to enhance its operations. Last October, the company announced the completed acquisition of MD Financial Management, a leading provider of financial services to physicians and their families. Scotiabank had completed its takeover of Jarislowsky Fraser Limited, an independent investment firms, earlier in the year. These acquisitions should allow Scotiabank to enter segments in which it has historically not been as successful as TD Bank.

Scotiabank’s strong international operations, particularly in Latin America, have helped revenues hit record highs recently, but the company has been shedding some of its operations abroad. Scotiabank sold operations in the Caribbean’s to cut costs, slash unprofitable units, and focus on high margin opportunities.

Valuation and recent dividend history

Scotiabank is currently trading at a 9.78 times future earnings, compared to 10.91 for TD bank. The two companies have comparable return on equity and net margin figures. Over the past 10 years, both banks have generally increased their dividend payouts, but TD’s increases have been interrupted by a sharp decrease.

Scotiabank’s dividends have been growing consistently, climbing 77% over the past 10 years. TD’s revenues have grown by 7% over the past five years, with its net income improving by 11%, slightly beating Scotiabank’s 6% revenue and net income growth over the same period. Both companies have conservative payout ratios, with TD’s 44.37% ratio beating out Scotiabank’s 50.07%.

The bottom line

While either stock would be a good addition to your TFSA, Toronto-Dominion Bank seems to edge Scotiabank in this battle. TD bank has better domestic operations, a stronger presence in the U.S., and generally records higher earnings and efficiency, and less exposure to risk. Scotiabank currently offers the higher dividend yield, and its recent dividend history is more impressive, but TD’s core operations and earnings potential likely has more upside in the long run.

Fool contributor Prosper Bakiny has no position in any of the companies mentioned. 

More on Dividend Stocks

diversification is an important part of building a stable portfolio
Dividend Stocks

TFSA Passive Income: 2 TSX Dividend Stocks to Consider Now

Building out a passive income portfolio with great TSX dividend stocks is easier than it sounds. Here are 2 stocks…

Read more »

top TSX stocks to buy
Dividend Stocks

How to Build a TFSA That Earns +$200 of Safe Monthly Income

If you want to earn monthly income, here is a four-stock portfolio that could collectively earn over $200 per monthly…

Read more »

Printing canadian dollar bills on a print machine
Dividend Stocks

My Blueprint for Generating $113/Month Using a $20,000 TFSA Investment

If you put $20,000 in and divide it 50/50 between both the companies, you could bring in around $113 in…

Read more »

A person's hand cupped open with a hologram of an AI chatbot above saying Hi, can I help you
Dividend Stocks

Is Telus Stock a Buy for Its Dividend Yield?

With a growth plan that is leveraging Telus' artificial intelligence advantages, Telus stock is positioning for strong long-term growth.

Read more »

Dividend Stocks

1 Outstanding Canadian Dividend Stock Down 10% to Buy and Hold for Years 

Explore the current challenges facing dividend stocks in the telecom sector and adapt to changing market conditions.

Read more »

Concept of multiple streams of income
Dividend Stocks

Invest $10,000 in This Dividend Stock for $580 in Passive Income

There’s no shortage of passive-income investments on the market. Here’s one that can provide $580 in annual dividends.

Read more »

person on phone leaning against outside wall with scenic view at airbnb rental property
Dividend Stocks

2 Dividend Stocks I’d Gladly Buy and Hold for Life

TELUS stock's 9% dividend yield is ripe for passive income builders as the company embarks on a noble cash flow…

Read more »

Nurse talks with a teenager about medication
Dividend Stocks

A 6.7% Dividend Stock That Remains a Standout Buy Into 2026

NorthWest Healthcare REIT’s hospital-backed leases and improving finances make it a defensive monthly payer to consider as rates ease in…

Read more »